<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=3190596&amp;fmt=gif">

CancerX Partnership Attracts 91 Founding Members

CancerX, a public-private partnership focused on cancer innovation, said Friday it has welcomed 91 founding member organizations representing payers, providers, pharmaceutical companies and digital health firms.

The Department of Health and Human Services’ Office for the National Coordinator for Health Information Technology and Office of the Assistant Secretary for Health are co-hosts of the partnership alongside the Tampa, Florida-based Moffitt Cancer Center and industry group the Digital Medicine Society. The partnership was announced by the White House in February as part of the Cancer Moonshot initiative, which was relaunched in 2022 and aims to cut cancer death rates in half over the next 25 years.

The 91 organizations include providers such as Memorial Sloan Kettering Cancer Center, MD Anderson and City of Hope Medical Center; digital health companies such as Thyme Care and Biofourmis; insurers such as Point32Health and Elevance Health and pharmaceutical companies such as AstraZeneca and the Janssen Pharmaceutical Companies of Johnson & Johnson. 

Click here to read the full article. 

Back to Blog